Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mayflower Bioscience
St. Louis, Missouri, United Statesmayflowerbio.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Mayflower Bioscience provides innovative research products for cell biology, molecular biology, drug discovery, infectious diseases, and COVID-19 testing, acting as a bridge for novel technologies (primarily from Europe) into the US market
- Modalities
- AntibodyReagentBioassayViral-based cell transfection solutionViral-based cell transduction solution
- Industry
- Drug Discovery Services
02
Partnerships
Cambridge Bioscience (UK life science distributor) – joined forces in October 2017 for broader support in North America and Europe
Beyond the preview
Go deeper on Mayflower Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mayflower Bioscience.